Friday, 18 October 2019

J&J's depression drug Spravato wins European panel vote

Johnson & Johnson's nasal spray for depression won recommendation for approval from a European Medicines Agency (EMA) panel, the regulatory body said on Friday.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)